- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Episode 7 - Inclusion of Generic Drugs in Pathways
Peter Salgo, MD; John L. Fox, MD, MHA; Ira M. Klein, MD, MBA, FACP; Michael Kolodziej, MD; and Bryan Loy, MD, discuss the factors influencing the inclusion of brand name and generic agents in medical oncology pathways.
Dr Kolodziej explains that the results of randomized clinical trials have shown the equivalence of certain generic treatment regimens to regimens that incorporate branded drugs. However, despite these results, not all pathways incorporate the use of generics.
Providers consider many factors when selecting a branded oncology drug over a generic, comment Drs Kolodziej and Klein. The first consideration is minimizing toxicity, followed by safety; last comes economics, according to Klein. Patient-specific factors also play a role, adds Kolodziej. For example, trastuzumab is always included in pathways for patients with HER-2-positive breast cancer.
Dr Salgo notes that when making treatment decisions, providers often feel pressured to adhere to a pathway to ensure that treatment is covered by insurance. However, Drs Klein, Loy, and Fox explain that programs have been established to ensure that providers can still treat their patients outside of a pathway.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
